Look Who’s On the Move!

      Gennao Bio Expands Leadership Team with Two Key Appointments

      HOPEWELL, N.J.--(BUSINESS WIRE)--Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, today announced the appointments of Joseph W. McIntosh,...

      Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio

      MORRISTOWN, N.J.--(BUSINESS WIRE)--Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that President and Chief Executive...

      RTW Investments Bolsters Leadership Team With Key Executive Appointments

      NEW YORK--(BUSINESS WIRE)--RTW Investments, LP (RTW), a global, full life-cycle investment firm focused on identifying transformational and disruptive innovations across the biopharmaceutical and medical...

      InterVenn Biosciences Names Brian Hogan as Chief Financial Officer

      SAN FRANCISCO--(BUSINESS WIRE)--InterVenn Biosciences, the leader in glycoproteomics, today announced that it has named Brian Hogan as Chief Financial Officer. In this strategic role,...

      Strateos Appoints Biopharma Executive Tom Rush, PhD to its Scientific Advisory Board

      MENLO PARK, Calif.--(BUSINESS WIRE)--Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, today announced...

      Recent Articles

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.